Context Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4 | -4 | ||
EBITDA | -9,689 | -9,754 | -5,525 | -4,307 |
EBIT | -9,693 | -9,758 | -5,529 | -4,310 |
Net Income | -9,693 | -8,827 | -4,577 | -3,342 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,578 | -5,835 | -5,062 | -4,907 |
Cash | 76,938 | 83,517 | 89,352 | 94,429 |
Basic Shares | 95,185 | 95,186 | 95,187 | 58,416 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -52 | -12 | -9 | |
EBITDA | -29,913 | -25,060 | -14,871 | -10,392 |
EBIT | -29,923 | -25,072 | -14,881 | -7,438 |
Net Income | -26,725 | -23,964 | -14,835 | -10,456 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,314 | -21,047 | -14,086 | -9,049 |
Cash | 94,429 | 14,449 | 35,497 | 49,635 |
Basic Shares | 58,416 | 15,966 | 15,966 | 2,834 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.10 |
2025-06-30 | -$0.09 |
